News — AI supercycle headlines

Simply Wall St.4h agoneutral

How Cannabis Rescheduling And BrewDog Deal Are Rewriting The Tilray Brands (TLRY) Investment Story

Tilray Brands’ fair value estimate currently stands at $10.04, with the latest update keeping this price target unchanged. Even with several analysts trimming their targets in both US$ and C$, others are turning more constructive after the partial cannabis rescheduling order and the BrewDog asset acquisition. As you read on, you will see how these competing views shape the evolving story around Tilray and what to watch as the narrative shifts. Analyst Price Targets don't always capture the...

Motley Fool6d agoneutral

It's Been 5 Years Since Tilray Merged With Aphria to Create a "Global Cannabis Leader." Here's How It's Done Since Then

Tilray's business has gotten bigger over the years, but it continues to struggle with achieving profitability.

Zacks10d agoneutral

Tilray Brands, Inc. (TLRY) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Tilray Brands (TLRY). This makes it worthwhile to examine what the stock has in store.

TLRY

Zacks11d agoneutral

Should SNDL Stock Be in Your Portfolio Post Q1 Earnings?

SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.

TLRY

Motley Fool13d agoneutral

Why Tilray's Marijuana Rescheduling Sizzle Has Fizzled

Most regulatory headwinds remain for cannabis companies like Tilray.

TLRY

Motley Fool15d agoneutral

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

Marijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon.

INTC TLRY

Insider Monkey16d agoneutral

Tilray (TLRY) CEO on Potential US Cannabis Reclassification

Tilray Brands, Inc. (NASDAQ:TLRY) is one of the 7 Best Hemp Stocks To Buy Now. On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. […]

TLRY

Motley Fool22d agoneutral

Is Tilray a Textbook Example of a Value Trap?

Tilray doesn't fit squarely into the value trap or value stock categories.

TLRY

TheStreet23d agoneutral

Tilray just showed how fast a policy trade can cool off

Tilray Brands (TLRY) surged in premarket trading on fresh enthusiasm over marijuana rescheduling, then gave back much of the move as the session unfolded. The early excitement followed a U.S. government shift to reclassify certain marijuana products and a market rush into cannabis names. By later ...

TLRY

Barrons.com23d agoneutral

Medical Marijuana Reclassified as Less Dangerous Drug. Pot Stocks Go Up in Smoke.

The Trump administration also announced the beginning of an expedited administrative hearing process to consider the rescheduling marijuana more broadly.

TLRY